163 related articles for article (PubMed ID: 9678798)
61. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
[TBL] [Abstract][Full Text] [Related]
62. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].
Yu YX; Shi YK; He XH; Zhou LQ; Zhou SY; Dong M; Feng FY; Sun Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2714-6. PubMed ID: 18167252
[TBL] [Abstract][Full Text] [Related]
63. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
[TBL] [Abstract][Full Text] [Related]
64. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F
Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
[TBL] [Abstract][Full Text] [Related]
65. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Winer EP; Lindley C; Hardee M; Sawyer WT; Brunatti C; Borstelmann NA; Peters W
Psychooncology; 1999; 8(2):167-76. PubMed ID: 10335560
[TBL] [Abstract][Full Text] [Related]
66. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Cordonnier C; de Bock R; Einsele H; Engelhard D; Grundy J; Link H; Locasciulli A; Prentice G; Reusser P
Bone Marrow Transplant; 1995 Mar; 15(3):455-60. PubMed ID: 7599572
[TBL] [Abstract][Full Text] [Related]
67. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
[TBL] [Abstract][Full Text] [Related]
68. [Autologous peripheral blood stem cell transplantation combined with autologous bone marrow transplantation for treating refractory lymphoma].
Chen XL; Su H; Zhong KL; DA Y; Xiao XB; Liu J; Yu JD; Zhang WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):155-9. PubMed ID: 19236769
[TBL] [Abstract][Full Text] [Related]
69. Immunity to polioviruses and tetanus after bone marrow transplantation in children.
Pezzini C; Limonta M; Rovelli A; Uderzo C; Locasciulli A; Maglia O; Masera G; Barbi M; Pozzi A; Luraschi C
Pediatr Hematol Oncol; 1994; 11(3):331-6. PubMed ID: 8060817
[TBL] [Abstract][Full Text] [Related]
70. [Studies on the immunity status against tetanus in Rhine-Hesse].
Pietsch M; Schütt KH
Offentl Gesundheitswes; 1991 Jun; 53(6):269-72. PubMed ID: 1833694
[TBL] [Abstract][Full Text] [Related]
71. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.
Lum LG; Seigneuret MC; Storb R
J Clin Immunol; 1986 Sep; 6(5):389-96. PubMed ID: 2429980
[TBL] [Abstract][Full Text] [Related]
72. Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.
Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
Transplantation; 2000 Apr; 69(8):1582-6. PubMed ID: 10836366
[TBL] [Abstract][Full Text] [Related]
73. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Gerritsen EJ; Van Tol MJ; Van 't Veer MB; Wels JM; Khouw IM; Touw CR; Jol-Van Der Zijde CM; Hermans J; Rümke HC; Radl J
Blood; 1994 Dec; 84(12):4374-82. PubMed ID: 7994052
[TBL] [Abstract][Full Text] [Related]
74. Active immunization against tetanus of children suffering with diabetes mellitus.
Solomonova K; Damiyanova K; Damiyanova M; Betovska M
Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):383-90. PubMed ID: 985669
[TBL] [Abstract][Full Text] [Related]
75. Objective verification of tetanus immune status in an apparently non-immune population.
Murphy NM; Olney DB; Brakenbury PH
Br J Clin Pract; 1994; 48(1):8-9. PubMed ID: 8179993
[TBL] [Abstract][Full Text] [Related]
76. Designed transfer of specific immune responses with bone marrow transplantation.
Saxon A; Mitsuyasu R; Stevens R; Champlin RE; Kimata H; Gale RP
J Clin Invest; 1986 Oct; 78(4):959-67. PubMed ID: 3531239
[TBL] [Abstract][Full Text] [Related]
77. [Initial evaluations on the use of passive microhemagglutination test for the verification of antitetanus immunity].
Borroni G; Gelosa L
Boll Ist Sieroter Milan; 1982 May; 61(2):121-7. PubMed ID: 7126336
[TBL] [Abstract][Full Text] [Related]
78. [Humoral immunity, 5 years after anti-tetanus vaccination, in a group of malaria-infected and malnourished African children].
Monjour L; Bourdillon F; Korinek AM; Aubonnet-Laignel A; Brousse G; Gentilini M; Bayard P; Ballet JJ
Pathol Biol (Paris); 1988 Mar; 36(3):235-9. PubMed ID: 3283686
[TBL] [Abstract][Full Text] [Related]
79. Nursing care issues in autologous bone marrow transplantation.
Whedon M; Damianos FL
Oncology (Williston Park); 1993 Jun; 7(6):78-88; discussion 91-2, 95. PubMed ID: 8318361
[TBL] [Abstract][Full Text] [Related]
80. Epidemiological Study of Tetanus Seropositivity Levels in Different Age Groups in Ankara Province, Turkey, 2017.
Sahan S; Demirbilek Y; Sonmez C; Temel F; Sencan I
Jpn J Infect Dis; 2019 Jan; 72(1):14-18. PubMed ID: 30175733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
